Form 4: Procter & Gamble COO Shailesh Jejurikar Reports Stock Option Grant
SEC Form 4
Chief Operating Officer of Procter & Gamble, Shailesh Jejurikar, reports the acquisition of stock options and adjustments to beneficial ownership of common stock.
Summary
- On September 13, 2024, Shailesh Jejurikar, the Chief Operating Officer of Procter & Gamble, reported transactions related to the company's stock.
- Jejurikar acquired 13,046 stock options with an exercise price of $174.08, exercisable from September 13, 2027, and expiring on September 13, 2034.
- The filing also indicates adjustments to the amount of common stock beneficially owned, including 9,855.9125 shares owned directly, 2,902.3575 shares held by a retirement plan trustee, 19,757 shares held by the Sankhya S Jejurikar Revocable Trust, and 17,849 shares held by the Shailesh Jejurikar Trust.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock option grants and changes in beneficial ownership, so the sentiment is neutral.
Positives
- The acquisition of stock options by a key executive can be seen as a positive sign, aligning their interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the holdings of a key executive at Procter & Gamble.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in publicly traded companies like Procter & Gamble.
- The terms of the options, such as the exercise price, vesting schedule, and expiration date, are generally aligned with industry standards for executive compensation packages.
- Comparing the size of the grant to those of executives at similar companies like Unilever or Colgate-Palmolive would provide further context.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the stock option transaction. |
| 09/13/2027 | Date the stock options become exercisable. |
| 09/13/2034 | Expiration date of the stock options. |
| 09/16/2024 | Date of the form filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.